PRO350 antibodies
The present invention is directed to novel polypeptides and to nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention.
Genetech, Inc.
Y C C C C G C C Y G A C G A C C C C G C C C G G C C A C C C C G C G C C G G C G G G C
Y10S C07K C07K C12Q C07K G01N C07K C07K Y10S G01N A61K C12N G01N A61K C12N C07K C07K C12Q G01N C07K C12N C07K G01N G01N C12P C07K A61K C12N C12P C12N C12N G01N C07K G01N C07K C12Q G01N G01N C07K G01N G01N G01N C12Q
additional inventional inventional inventional inventional inventional additional inventional additional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional additional inventional inventional additional inventional inventional additional inventional inventional inventional inventional additional additional inventional inventional additional inventional inventional inventional additional
William I. Audrey Maureen Timothy A. Colin K. Paul J. Mary E. Luc Austin L. Daniel Kevin P. Zemin Victoria Ellen Wei-Qiang Steven Laura
Wood Goddard Beresini Stewart Watanabe Godowski Gerritsen Desnoyers Gurney Tumas Baker Zhang Smith Filvaroff Gao Sherwood DeForge